SPONSOR
NS Pharma, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: Pulmonary Arterial HypertensionPulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NS Pharma, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD).
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — NS Pharma, Inc.
How many clinical trials has NS Pharma, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by NS Pharma, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does NS Pharma, Inc. research focus on?
NS Pharma, Inc. clinical trials span Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD). The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a NS Pharma, Inc. clinical trial?
To participate in a NS Pharma, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all NS Pharma, Inc. trials with current recruitment status updated daily.
Clinical Trials by NS Pharma, Inc.
NCT07441200 Phase 2
Recruiting
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension
NCT07441278 Phase 2
Recruiting
A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology